logo

For the Inventor, By the Inventor

Cincinnati, OH, United States of America

Eugene L Giroux

This inventor holds 15 USPTO granted patents, plus 2 CIPO patents, primarily in Peptidase Inhibitors. Top assignees: Merrell Toraude Et Compagnie, Merrell Pharmaceuticals, Inc., Merrell Dow Pharmaceuticals. Active years: 1976-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eugene L Giroux. Retrieved from https://idiyas.com/inventor/eugene-l-giroux

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15

% Patents Active = 100.0


Average Co-Inventor Count = 2.9

ph-index = 7

Forward Citations = 148(Granted Patents)


Location History:

  • Strasbourg, FR (1976 - 1978)
  • Cincinnati, OH (US) (1978 - 2000)

Company Filing History:

goldMedal5 out of 48 
 
Merrell Toraude Et Compagnie
 patents
silverMedal4 out of 194 
 
Merrell Pharmaceuticals, Inc.
 patents
bronzeMedal2 out of 455 
 
Merrell Dow Pharmaceuticals
 patents
4. 2 out of 167 
 
Richardson-Merrell Inc.
 patents
5. 1 out of 1,217 
 
The United States of America as Represented by the Department of Health
 patents
6. 1 out of 834,601 
Other
 patents

Years Active: 1976-2000

Loading Chart...
Loading Chart...
Areas of Expertise:
Peptidase Inhibitors
Mercaptoacetylamide Derivatives
Enkephalinase
Snake Bite Therapy
Dithiobis
Hypertension Treatment
Zinc Supplementation
Obesity Control
Active Principles
Therapeutic Applications
15 patents (USPTO):Explore Patents
1. 6130315 - Peptidase inhibitors (2000-10-10),
2. 5849866 - Peptidase inhibitors (1998-12-15),
3. 5527795 - Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase (1996-06-18),
4. 5496927 - Peptidase inhibitors (1996-03-05),
5. 5491143 - Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase (1996-02-13),
6. 5430145 - Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase (1995-07-04),
7. 4439443 - Snake bite therapy (1984-03-27),
8. 4347255 - Snake bite therapy (1982-08-31),
9. 4226882 - Use of .alpha.,.alpha.'-dithiobis-(.beta.-arylacrylic acid) derivatives (1980-10-07),
10. 4210665 - Use of .alpha.,.alpha.'-dithiobis(.beta.-arylacrylic acid) derivatives (1980-07-01),
11. 4210664 - Use of .alpha.,.alpha.'-dithiobis(.beta.-arylacrylic acid) derivatives (1980-07-01),
12. 4169149 - Use of .alpha.-mercapto-.beta.-arylacrylic acid derivatives in heavy (1979-09-25),
13. 4130653 - Method of treating hypertension (1978-12-19),
14. 4124718 - Enhancing zinc serum and tissue levels (1978-11-07),
15. 3995031 - Method of controlling obesity with purified active principle of fruit of (1976-11-30),

Title: Eugene L Giroux: Pioneering Innovation in the Field of Peptidase Inhibitors

Introduction:

Eugene L Giroux, based in Cincinnati, OH, is a visionary inventor whose passion for innovation and relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology. With a total of 15 patents to his name, Giroux has made significant contributions to the field of peptidase inhibitors.

Latest Patents:

Giroux's latest patents revolve around the development of analogs of peptidase substrates, in which the amide group containing the scissile amide bond of the substrate peptide is replaced by an activated electrophilic ketone moiety. These analogs of peptidase substrates serve as specific enzyme inhibitors for various proteases, offering valuable physiological implications in numerous disease states.

Career Highlights:

Having worked in renowned companies like Merrell Toraude Et Compagnie and Merrell Pharmaceuticals, Inc., Giroux has demonstrated his expertise and leadership in the pharmaceutical industry. His innovative solutions have paved the way for advancements in drug development and therapeutic interventions.

Collaborations:

Throughout his career, Giroux has collaborated with esteemed professionals in the field, including Nellikunja J Prakash and Paul J Schechter. Together, they have collectively worked towards pushing the boundaries of scientific research and fostering a culture of innovation and collaboration.

Conclusion:

Eugene L Giroux's remarkable journey as an inventor exemplifies the power of relentless dedication and a commitment to pushing the boundaries of what is possible. His groundbreaking work in the development of peptidase inhibitors stands as a testament to his pioneering spirit and unwavering pursuit of excellence, inspiring both current and future generations of inventors to continue driving technological advancements for the betterment of society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…